Remicade News
Most Popular Remicade Story
J&J wants a piece of Merck/Schering action
We hear Johnson & Johnson is twisting a few arms at Schering-Plough. The Financial Times quotes sources close to the talks, saying that J&J is prepping for a legal challenge to Schering's... Read more...
Latest Headlines
- November 13, 2009
- August 5, 2009
- May 28, 2009
- May 21, 2009
- April 24, 2009
- March 30, 2009
- October 24, 2008
- September 5, 2008
- July 21, 2008
- June 5, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
